The authors report the single institution experience on patient outcomes in this group using high–dose palliative radiotherapy (HDPRT). HDPRT was well tolerated and provided a high rate of local control in a clinically localised castration–resistant prostate cancer population.

Although prostate cancer remained the most frequent cause of death, some patients had extended survival without evidence of disease progression.

READ FULL ARTICLE Curated publisher From Mdlinx